Here’s why Sage Therapeutics fell 18% on Tuesday morning

Sage Therapeutics Inc (NASDAQ: SAGE) said on Tuesday its candidate drug for depression that it developed in collaboration with Biogen Inc was found effective in alleviating the symptoms, as per the results of the late-stage trial. Despite meeting the goal of the study, Sage’s stock tanked about 18% this morning.   The news comes only […]